ACFN vs GSK · P/E 22, rev $4.7M vs P/E 13, $103.31B cap
Acorn Energy, Inc. Common Stock (ACFN) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Acorn Energy, Inc. Common Stock (ACFN) is a scientific & technical instruments company listed on NASDAQ.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported ACFN revenue for 2026-06-30 was $4.7M. Net income was $217.0K. ACFN currently screens at market cap $43.0M and trailing P/E 22.3.
GSK does not have a complete income-statement cache yet.
ACFN currently screens at market cap $43.0M and trailing P/E 22.3. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the ACFN and GSK stock pages for the full models.
Not investment advice.